Other OTC Pharmaceuticals (Pharmacies) - Central America

  • Central America
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$115.30m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.53%, resulting in a market volume of US$124.40m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$2.18 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Central America has been experiencing significant growth in recent years. Customer preferences in the region have played a key role in driving this growth. Central American consumers have a strong preference for self-medication and over-the-counter (OTC) medications, which has led to increased demand for these products. This preference can be attributed to several factors, including convenience, cost-effectiveness, and a cultural belief in the efficacy of OTC medications. In addition to customer preferences, several trends have emerged in the Central American Other OTC Pharmaceuticals (Pharmacies) market. One notable trend is the increasing availability of OTC medications in pharmacies. Pharmacies in the region have expanded their product offerings to include a wide range of OTC medications, making them easily accessible to consumers. This trend has been driven by the growing demand for OTC medications and the desire of pharmacies to meet the needs of their customers. Another trend in the market is the growing popularity of natural and herbal OTC medications. Central American consumers are increasingly seeking out natural alternatives to traditional pharmaceutical products, driven by a desire for more holistic and sustainable healthcare options. This trend has led to an increase in the availability and variety of natural and herbal OTC medications in pharmacies across the region. Local special circumstances also contribute to the development of the Other OTC Pharmaceuticals (Pharmacies) market in Central America. One such circumstance is the relatively low access to healthcare services in some areas of the region. In these areas, pharmacies often serve as the primary source of healthcare for many individuals, leading to increased demand for OTC medications. Additionally, the presence of a large informal economy in Central America has created a demand for affordable healthcare options, further driving the growth of the OTC Pharmaceuticals market. Underlying macroeconomic factors have also played a role in the development of the market. Central America has experienced steady economic growth in recent years, which has resulted in an increase in disposable income for many consumers. This increase in disposable income has allowed consumers to spend more on healthcare products, including OTC medications. Additionally, improvements in healthcare infrastructure and access to healthcare services have also contributed to the growth of the market. Overall, the Other OTC Pharmaceuticals (Pharmacies) market in Central America is developing due to customer preferences for self-medication, the availability of OTC medications in pharmacies, the popularity of natural and herbal products, local special circumstances, and underlying macroeconomic factors. As these trends continue to shape the market, it is expected that the market will continue to grow in the coming years.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)